Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
about
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisNSAIDs do not require the presence of a carboxylic acid to exert their anti-inflammatory effect - why do we keep using it?Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.Spondyloarthritides: evolving therapiesDiagnosis and management of ankylosing spondylitis.Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway.ASAS/EULAR recommendations for the management of ankylosing spondylitis.Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritisAn evidence-based update on nonsteroidal anti-inflammatory drugs.Management and evaluation of extra-articular manifestations in spondyloarthritisDevelopments and current pharmacotherapeutic recommendations for ankylosing spondylitis.The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.Tai chi for disease activity and flexibility in patients with ankylosing spondylitis--a controlled clinical trial.Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.Infliximab in the treatment of ankylosing spondylitis.Treatment of ankylosing spondylitis: focus on etanercept.Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.Managing pain in inflammatory bowel disease.First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.Treatment of extraintestinal manifestations in inflammatory bowel disease.Extraintestinal manifestations and complications in IBD.The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritisEfficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses.The effectiveness of specific exercise types on cardiopulmonary functions in patients with ankylosing spondylitis: a systematic review.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesAnkylosing spondylitis - the changing role of imaging.Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study.Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study.Comparison of Deep Tissue Massage and Therapeutic Massage for Lower Back Pain, Disease Activity, and Functional Capacity of Ankylosing Spondylitis Patients: A Randomized Clinical Pilot Study.Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis.A life-threatening abscess in a patient treated with a tumour necrosis factor-alpha antagonist: a case report.Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.Anti-inflammatory and anti-nociceptive effects of Zeyheria montana (Bignoniaceae) ethanol extract.
P2860
Q24603648-1C854A15-EB6E-4A74-8CBE-30722F101BC1Q30996980-451529B1-E7C7-48DE-8AE1-D10AA2B5F81EQ33602465-5388CFE1-073F-4EAD-BC4C-35DB26A09102Q33923298-1DA532FE-AF10-4F37-9420-415723F397D1Q34152778-4DED5800-28DD-44A4-9CEC-45B3170E55E6Q34449888-354E02D7-20E5-43CA-AB4D-FB9319F43387Q34613907-9F57A1E3-752F-458E-9726-81BDA452AD1AQ35039166-FEAA843C-23D8-4669-A89A-C9B5D3A5DF49Q35098611-DC9AF181-639B-49AA-8DD7-309EF65C0006Q35637012-EDDA4DA7-69C8-4FCF-AB09-0E70C694DFDFQ35694939-97057AA7-5320-4B40-AA3C-C8A8CC24156AQ35758411-7B8F797F-962C-462F-B694-20F54BF29281Q36439889-98637137-C14F-4910-8CB1-B322A974F683Q36458447-F1617B1E-37D3-4DC6-B1F8-B89F6DFFBD1DQ36940942-9E431BBC-6D78-4B5E-84E2-AAC4F19D259DQ36981170-6461D8AE-D492-4321-B7D6-364FCDECC49AQ37085249-48D068E1-692A-45C6-8607-12724341B05CQ37290474-70EAADB4-726A-4464-819D-E5F6A2D2B229Q37290601-94DC339E-C6EB-4BB6-80BD-8BB930F8AE2DQ37307268-44E1BFC2-06BF-41BB-900A-6138ECE0C2CBQ37612248-30066638-D9A1-49ED-A224-52C282DDE478Q37688137-68457D71-1AE0-441A-BA6D-73AC95414921Q37980743-0E44064B-5DE2-4F34-88EE-EF327D6187CFQ38003531-53C876F9-0B43-4BEE-91FA-B4D8C34F00B2Q38049779-E7C2957B-0DB3-463B-91E5-5C76FC84A4A5Q38050884-D1E8ACD2-F4A9-4747-815C-A601DAE67B19Q38120146-06683568-E71D-40ED-882A-D0F15F0F3B1CQ38648484-7E88B6B2-6742-45B4-948B-D9C6300FCF6FQ38972623-CEDCE5B2-034B-4D0F-863F-1F2C2811962BQ38993297-A9B8DD82-AEFE-4425-A0C5-45CA8D4CA175Q39006007-DAA938F5-D762-4132-9A8E-C3EAF766364CQ39339379-AD067265-1AEE-484D-A3E5-D949DE18F8EAQ39598494-FECF2872-0A9A-465C-9B77-3E86E5A463CFQ40318692-15CFF268-8B73-433F-ADA9-2C5B435321FDQ41231679-2B2AE8E0-D260-4182-8B26-B480629E2D5EQ41463455-1B6501E1-4B0F-45D9-9020-717810E2C6EBQ42955475-37E7B4A4-1EEC-4967-BF5E-50D573FEE448Q43282843-ADC2040B-2EF3-464C-9A18-2501879F04AEQ45229094-922BC60E-F4FE-49DF-8217-F78E2AFBF2D9Q46160460-1FAFDC3F-3F38-4106-8B71-136092218A69
P2860
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Current evidence for the manag ...... ions in ankylosing spondylitis
@ast
Current evidence for the manag ...... ions in ankylosing spondylitis
@en
type
label
Current evidence for the manag ...... ions in ankylosing spondylitis
@ast
Current evidence for the manag ...... ions in ankylosing spondylitis
@en
prefLabel
Current evidence for the manag ...... ions in ankylosing spondylitis
@ast
Current evidence for the manag ...... ions in ankylosing spondylitis
@en
P2093
P2860
P356
P1476
Current evidence for the manag ...... ions in ankylosing spondylitis
@en
P2093
P2860
P304
P356
10.1136/ARD.2005.041129
P407
P577
2005-08-26T00:00:00Z